Archive for category: HIV/AIDS

, ,

People Living With HIV/AIDS in Samoa

HIV/AIDS in SamoaHIV/AIDS places a heavy burden on the health care system of Samoa, which already is known to operate with limited resources. Managing the disease requires consistent access to antiretroviral therapy, testing and long-term care services that are costly and not always easily accessible. These costs can lead to financial hardship for affected families, driving them deeper into poverty. Additionally, as individuals become too ill to work, household incomes shrink and national productivity declines.

Health Care Capacity: Data-Driven Constraints

As of 2022, Samoa allocates 6.3 % of its gross domestic product (GDP) to health, one of the highest rates among Pacific Island nations, compared to a global average of 9.8%. However, this spending is stretched: the government covers approximately 75% of that, with external aid contributing 13% and out-of-pocket spending comprising 11%.

Despite this investment, Samoa’s health workforce remains critically low, with only 0.55 physicians per 1,000 people. This falls far below the global average of 1.7 and the European Union’s 4.1 per 1,000. The World Health Organization (WHO) recommends at least 2.5 medical professionals (including nurses, midwives and physicians) per 1,000 people, yet Samoa’s national average remains below that. Rural areas fare worse, with just one health worker per 1,000 people, while some urban centers report up to eight per 1,000, according to International Health Strategies.

The imbalance means rural communities are underserved, central hospitals are overburdened and preventive outreach is limited. Faced with a dual disease burden, noncommunicable diseases like diabetes and rising infectious threats like HIV and Tuberculosis (TB) limit the workforce and curtail Samoa’s ability to mount widespread prevention and treatment campaigns.

HIV/AIDS in Samoa

As of the most recent public reports, Samoa has reported only 12 individuals living with HIV, all receiving antiretroviral treatment and in stable health, with no new locally acquired cases since 2020. A national population of approximately 216,000 (2023) means HIV prevalence is 0.005%, far below the Western Pacific regional average of 0.1%. Since 1990, 24 total cases have been recorded, with 11 still living as of the 2016 UNAIDS report. Still, low testing rates, 4–5 % of the population yearly, suggest some infections may go undetected.

People living with HIV/AIDS in Samoa often face significant stigma, leading to discrimination in their workplace and their communities. This social exclusion contributes to job loss and a lack of access to support services. This traps individuals in cycles of poverty. In a small economy, where every job counts, the loss of employment due to health-related stigma is especially damaging.

Global Support and Development Goals

International aid has been vital in Samoa’s fight against HIV/AIDS, funding prevention and treatment efforts that also strengthen education and health care. Viewing HIV as both a health and development issue makes aid more impactful and sustainable.

A key project supporting Samoa’s HIV response is the Global Fund–backed Multi-Country Western Pacific Integrated HIV/TB Program. It was implemented by the United Nations Development Project (UNDP) and Samoa’s Ministry of Health. The program focuses on testing, prevention, treatment and community outreach across 12 Pacific nations.

Conclusion

HIV/AIDS in Samoa is more than just a medical concern. It is a challenge that intersects poverty, social justice and economic development. Combating the epidemic requires medicine, education, compassion and strong international partnerships.

– DeMarlo Jon Gray

DeMarlo is based in Long Beach, CA, USA and focuses on Global Health and Politics for The Borgen Project.

Photo: Unsplash

, ,

Ending Mother-To-Child HIV Transmission in Botswana

Mother-To-Child HIV TransmissionIn a landmark achievement for global health, Botswana has become the first country with a high HIV burden to earn the World Health Organization’s (WHO) prestigious Gold Tier certification for eliminating mother-to-child transmission (MTCT) of HIV. As of 2023, Botswana has reduced vertical HIV transmission rates to just 1.2%, with fewer than 100 babies born with HIV annually. This is a remarkable feat given the country’s previously severe HIV epidemic.

A Triumph Against the Odds

Botswana has long been one of the nations hardest hit by HIV/AIDS, with adult prevalence rates among the highest in the world. Yet, through committed public health efforts, the country has demonstrated that even in high-prevalence settings, eliminating new pediatric HIV infections is achievable.

The WHO’s Gold Tier status is awarded to countries that meet rigorous criteria for the elimination of mother-to-child transmission, including maintaining transmission rates below 2% and sustaining this achievement over time. Botswana’s attainment of this status is a testament to its effective health policies, strong political will and dedicated community programs.

Keys to Success: Universal Treatment and Comprehensive Care

Central to Botswana’s success has been the provision of universal free antiretroviral treatment (ART) to all pregnant women living with HIV. This policy ensures that pregnant women receive the medication necessary to suppress the virus, drastically reducing the chance of passing HIV to their babies.

Moreover, Botswana boasts high rates of antenatal care attendance and widespread HIV testing among pregnant women. Early diagnosis and continuous monitoring throughout pregnancy enable timely intervention and care adjustments, maximizing the chances of a healthy, HIV-free birth.

Complementing clinical care, robust community-based health programs have played a critical role. These programs provide education, support and follow-up services, ensuring that women stay engaged in treatment and adhere to prescribed regimens.

A Model for the World

Botswana’s achievement in reducing mother-to-child HIV transmission not only saves countless children from HIV but also offers a blueprint for other countries facing high HIV burdens. It challenges the notion that eliminating vertical transmission is unattainable in resource-limited, high-prevalence environments. The country’s success underscores the power of integrating free, accessible health care services with community engagement and strong political commitment. It also highlights the importance of sustained investments in maternal and child health programs.

While Botswana’s milestone is cause for celebration, continued vigilance is essential. Maintaining low transmission rates requires ongoing support for pregnant women, access to ART and community outreach. Indeed, Botswana’s experience demonstrates that with the right strategies and resources, the goal of an HIV-free generation is within reach, even in the most challenging settings.

As global health organizations and countries worldwide strive to eliminate pediatric HIV, Botswana stands as a beacon of hope, proving that with determination and comprehensive care, vertical transmission of HIV can be stopped.

– Meagan Beaver

Meagan is based in Zephyrhills, FL, USA and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

,

Addressing HIV/AIDS in Kyrgyzstan

HIV/AIDS in KyrgyzstanHIV/AIDS remains a big public health issue in many parts of the world, and Kyrgyzstan is no exception. The country has made some progress in fighting the spread of the virus, health care system limitations, societal barriers and lack of sufficient public awareness continues to fuel its spread. Raising awareness and understanding the landscape of HIV/AIDS in Kyrgyzstan is essential for creating effective solutions that aim to rid the nation of such devastating diseases.

HIV/AIDS Demographics

The median age for HIV/AIDS in Kyrgyzstan is about 31. The prevalence rate is nearly 15% among those who inject drugs, and 0.2% rate among the entire population–about 14,600. Men account for a slight majority, having about 60% of the cases while women account for the latter 40%. Impoverished communities—especially injecting drug users, sex workers and migrants—normally have higher HIV vulnerability due to their economic strain, need and limited access to resources.

Health Care Challenges

Kyrgyzstan’s health care system faces big challenges when it comes to managing HIV/AIDS. While the country provides free antiretroviral therapy to people living with HIV, access to consistent and high-quality treatment is not equitable or equal, especially in rural and mountainous regions.

Diagnostic tools and lab equipment are not always available or up to international standards, and logistical delays can mean late diagnoses—when the virus has already progressed significantly, leading to more probable death.

Barriers to Prevention

One of the most significant hurdles to stopping the spread of HIV in Kyrgyzstan lies in social and cultural attitudes. HIV/AIDS is still highly stigmatized and is often associated with marginalized groups such as people who inject drugs or sex workers. This creates an environment of fear, where individuals at risk are reluctant to get tested for HIV. 

In schools, education on this topic is minimal or nonexistent. As a result, many young people grow up without basic knowledge about how HIV transmits or how people can prevent it. Additionally, many have misconceptions about HIV/AIDS. Public health campaigns have improved over the years, but they often fail to reach the most at-risk communities, such as rural communities. 

Injection drugs–via needle–remains one of the main transmission routes of HIV in Kyrgyzstan. Harm reduction strategies do exist, but their reach is limited, commonly only reaching citizens in either Osh or Bishkek and being held back by the stigma.

The Way Forward

To address the HIV/AIDS epidemic in Kyrgyzstan, investment in health care infrastructure is critical. This means not only economically supporting increased medical equipment and laboratories through donors, but also training health care professionals in modern HIV treatment protocols and in how to provide care without stigmatization. Improving access to health care in rural and underserved areas through mobile clinics could bridge existing gaps.

Many NGOs in Kyrgyzstan are already doing essential work in reaching vulnerable populations and offering services including the CDC–PEPFAR Partnership in Kyrgyzstan. The CDC–PEPFAR project began in 2011 when the U.S. CDC launched HIV programs under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Viral load suppression improved from around 44% in 2016 to 95% in 2024, PrEP became available to high-risk individuals and ART has now been provided in 26 AIDS centers, serving more than 4,150 individuals.

Looking Ahead

The fight against HIV/AIDS requires collaboration between the government, citizens and the international community. More importantly, however, the mitigation of HIV/AIDS in Kyrgyzstan requires a commitment to the wellbeing of every citizen.

– Jackson Mailer

Jackson is based in Brooklyn, NY, USA and focuses on Global Health and Politics for The Borgen Project.

Photo: Unsplash

, ,

The Fight Against HIV in Suriname

hiv surinameWith a population of just 640,000, Suriname is both the least populated nation on the continent and the smallest in size. Despite its modest scale, Suriname stands out as a constitutional democracy where Christianity remains the dominant faith. Although it rarely makes international headlines, the country deserves attention, not only for its rich cultural diversity but also for the pressing challenges its people continue to face, for example, the fight against HIV in Suriname.

The Prevalence of HIV

The prevalence of HIV is pretty high, estimating for almost 8,000 people per year, most of them being adults. Men are at a higher risk of this disease. In Suriname, the lack of up-to-date and detailed data on HIV prevalence continues to hinder effective policymaking. To address this, international support helped strengthen national statistics offices across the region, improving data collection and reporting.

However, economic challenges such as currency devaluation and inflation have led to major cuts in health spending, resulting in frequent shortages of antiretroviral treatment. Experts emphasize the need for renewed advocacy and updated investment cases to ensure the sustainability of HIV services.

Key Groups in the Fight Against HIV in Suriname

In Suriname, NGOs play a central role in HIV prevention among sex workers and men who have sex with men. Their outreach includes individual counseling, group education sessions, condom and lubricant distribution, and referrals to health services. For sex workers in gold mining areas, prevention efforts are integrated with malaria programs. These initiatives have shown clear success.

HIV prevalence among sex workers in Paramaribo dropped significantly, from 24.1% in 2005 to 5.8% in 2012. Most sex workers now demonstrate strong awareness of HIV prevention (96.5%), high rates of testing (82.7%), and frequent condom use (90%), according to the UNAIDS report. Still, challenges remain, particularly with consistent and correct condom use. The prevalence among sex workers remains higher than in the general population, highlighting the need for ongoing targeted interventions.

The Link Between Poverty and HIV in Suriname

The fight against HIV in Suriname cannot be separated from the country’s broader social and economic challenges. More than 17% of the population lives in poverty, while 1.1% survives in extreme poverty. Poverty is especially pronounced among households with children and in the center of the country, living much below the average poverty line. These economic hardships could directly affect the national HIV struggles. Limited household resources often mean reduced access to health care, HIV testing, and consistent treatment. What is more,  women—despite outperforming men in education—remain underrepresented in the workplaces, leaving them economically vulnerable and at greater risk of health inequities.

Fighting the Disease

Suriname has made significant progress in the fight against HIV, with support from the Global Fund and local civil society organizations. Today, 83% of diagnosed individuals are receiving antiretroviral treatment, and 90% of them have achieved viral suppression — a major step toward the UNAIDS 90-90-90 targets.

As international donor funding gradually phases out, Suriname faces the critical challenge of sustaining these achievements domestically. The country’s Sustainability Action Plan for 2021–2024 makes strategies to maintain HIV prevention and treatment services, expand local funding and continue prioritizing key populations. With sustained commitment and focused action, the fight against HIV in Suriname can continue to yield progress and bring the country closer to ending the epidemic.

– Julia Skowrońska

Julia is based in Wrocław, Poland and focuses on Global Health for The Borgen Project.

Photo: Flickr

, ,

HIV/AIDS in Armenia

HIVAIDS in ArmeniaAlthough Armenia maintains a low national HIV prevalence—less than 0.2%, the number of new infections has steadily increased in recent years. Between January and October 2024, health authorities recorded 462 new HIV cases, bringing the total number of registered infections since 1988 to approximately 6,076. According to Anna Mergelyan, head of Monitoring and Evaluation at the National Center for Infectious Diseases, the primary transmission route was heterosexual contact (81%), followed by homosexual contact (12%) and injecting drug use (6%).

Rising Infections Among Key Populations

While the national prevalence of HIV remains low, the virus disproportionately affects vulnerable groups. Integrated Bio-Behavioral Surveillance (IBBS) studies and independent reporting indicate that HIV prevalence among men who have sex with men (MSM) increased from 2.7% in 2018 to approximately 5.0% in 2021. Additional risk groups include people who inject drugs (2.6%), transgender individuals (2.5%) and sex workers (0.2%). These trends underscore the need for targeted prevention services, especially in urban areas like Yerevan and regional centers such as Gyumri and Shirak.

HIV/AIDS Stigma and Health Care Barriers in Armenia

Despite the availability of free HIV testing and antiretroviral therapy (ART), stigma in health care settings remains a significant barrier. People living with HIV/AIDS in Armenia frequently report being denied services, especially in nonspecialized clinics. Zhenya Mayilyan, head of the NGO Real World, Real People, stated, “If we compare the situation 10 years ago and now, a lot has changed – both in the public perception and in the level of people’s awareness. However, people living with HIV in Armenia are discriminated against in various spheres of life, in particular, in medical institutions, where a person has to report his or her HIV status when they need some kind of medical intervention.”

She also highlighted specific instances of discrimination, such as a case where an HIV-infected person with a second group of disabilities was refused a spinal tap in two well-known medical centers in Yerevan. The procedure was only carried out after the intervention of a social worker from a public organization.

National Progress and Global Recognition

Armenia became one of the first countries in the World Health Organization (WHO) European Region to eliminate mother-to-child transmission of both HIV and syphilis—a milestone officially recognized by the WHO in 2018. The achievement followed years of investment in maternal health screening, antiretroviral access and prenatal care. Between 1996 and 2010, the country registered 968 HIV cases, with more than 400 progressing to AIDS. A peer-reviewed study in the Journal of AIDS and HIV Research found that most infections occurred among men aged 30 to 39 and more than half had links to heterosexual contact or injecting drug use.

More recently, Armenia has made significant progress toward meeting UNAIDS’ “95-95-95” targets. By late 2022, approximately 77% of people living with HIV were aware of their status, 81% of those diagnosed were receiving ART and 86% of those on treatment had achieved viral suppression.

Community Efforts and Harm Reduction

Local NGOs, such as Real World, Real People, Pink Armenia and Right Side, continue to lead the HIV response at the grassroots level. These organizations provide mobile testing services, legal advocacy, peer support networks, and psychosocial care. Pre-exposure prophylaxis (PrEP) access has also expanded through donor-supported pilot programs.

While government reporting suggested that more than 18,000 individuals from high-risk groups received HIV prevention services in recent years, exact figures are not publicly available in English-language government databases. Independent sources note that outreach efforts remain strong, with HIV testing coverage exceeding 90% for groups such as MSM and people who inject drugs.

Moving Forward

HIV/AIDS in Armenia remains a concentrated but growing public health concern. The country has taken bold steps—from eliminating mother-to-child transmission to reaching strong treatment coverage levels—but stigma, rising infections and inadequate legal protections continue to threaten progress. Continued investment in public education, stigma reduction, legal reform and NGO-led outreach can potentially ensure that all Armenians—regardless of background or identity—have access to lifesaving HIV prevention and care.

– Mamie Hirsh

Mamie is based in Berkeley, CA, USA and focuses on Good News and Celebs for The Borgen Project.

Photo: Flickr

, ,

Everything To Know About HIV/AIDS in Mongolia

HIVAIDS in MongoliaMongolia is a vast country in East Asia, bordered by China and Russia, with a population of about 3.5 million people, nearly half of whom live in the capital city, Ulaanbaatar. Once part of the Mongol Empire and later a Soviet satellite, Mongolia has undergone a rapid political and economic transformation since the 1990s. Today, it is a democratic state with a growing, resource-based economy. However, the country still faces infrastructure gaps, urban-rural inequality and a fragile health system stretched across immense distances.

In the context of public health, Mongolia has been largely spared from large-scale epidemics. HIV prevalence remains low, but that does not mean the risk is absent. For a nation often overlooked in global health discussions, Mongolia’s quiet battle against HIV is a story of early success—and urgent, unfinished business. Here is information about HIV/AIDS in Mongolia and efforts to combat it.

The Prevalence of HIV/AIDS in Mongolia

Mongolia has maintained a low overall HIV prevalence, estimated at around 600 people living with HIV in 2023. Men account for a significantly larger proportion of cases than women. While the numbers remain low compared to other countries, the number of cases has been slowly increasing over time. This highlights the need for sustained prevention efforts and real awareness campaigns.

The country reports fewer than 100 AIDS-related deaths annually, a reflection of progress in raising awareness, early detection and improved access to antiretroviral therapy (ART). However, treatment coverage remains below international targets; approximately 39% of people living with HIV receive ART, falling short of the UNAIDS 95-95-95 goals aimed for 2030. Without adequate treatment, the virus risks spreading further, especially among vulnerable populations.

Key Populations Most Affected by HIV/AIDS

Sexual contact is the primary mode of transmission. Certain groups carry a disproportionate burden of HIV infection:

  • Men who have sex with men face stigma and discrimination, which discourages them from seeking timely treatment.
  • Sex workers are at higher risk due to multiple partners and inconsistent condom use, compounded by social barriers to health care.
  • Transgender people experience similar stigma, limiting their access to prevention and treatment services.
  • People who inject drugs face heightened risk due to needle sharing, with limited awareness of safe injection practices in Mongolia.

Poverty and HIV/AIDS in Mongolia

Poverty exacerbates vulnerability to HIV infection and limits access to health care services in Mongolia. Many people living in poverty, particularly in rural and ger (traditional tent) districts around Ulaanbaatar, face barriers such as transportation costs, limited health care infrastructure and social stigma. These challenges reduce access to testing and treatment, increasing the risk of undiagnosed and untreated infections.

Mongolia’s Efforts To Address HIV/AIDS

To address these challenges, Mongolia has implemented several programs focused on vulnerable populations and poverty reduction:

  • Since August 2023, the Payment-for-Results model has incentivized NGOs to increase HIV testing and outreach among key populations, linking funding to performance outcomes.
  • The Undarga microfinance program, piloted since 2010, targets women engaged in sex work, offering financial education and savings services to reduce reliance on risky income sources.
  • Mobile health clinics that have support from the World Health Organization (WHO) and international partners bring HIV testing and health care services to rural and nomadic communities, overcoming geographic and economic barriers.

Looking Ahead

Mongolia has kept HIV prevalence and AIDS-related deaths relatively low, but a slow rise in new cases, especially among impoverished and stigmatized groups, presents ongoing challenges. Addressing poverty’s role in HIV vulnerability and improving health care access through innovative programs and sustained investment will be essential for Mongolia to sustain its progress and meet international targets. With continued commitment, Mongolia can look forward to a healthier future.

–  Julia Skowrońska

Julia is based in Wrocław, Poland and focuses on Global Health for The Borgen Project.

Photo: Flickr

,

The HIV Epidemic in Eastern Europe and Central Asia

HIV Epidemic in Eastern EuropeElton John is famous for his philanthropy work, contributing to those affected by HIV/AIDS globally. He created the Elton John AIDS Foundation, whose mission is to end the HIV/AIDS epidemic. People can be happy and healthy with HIV, but 15 million people are not able to receive treatment today because they are restricted in their own societies. Most new HIV infections are in marginalized groups, and these groups face abandonment, discrimination, and violence. This prolongs the AIDS epidemic by stopping people in these groups from accessing life-saving treatment and services. The Elton John AIDS Foundation challenges discrimination, prevents infections, and provides treatment for marginalized groups, while also mobilizing governments to put an end to AIDS.

What is the Elton John AIDS Foundation Doing Now?

The Foundation implemented the RADIAN initiative in 2019 to address the HIV Epidemic in Eastern Europe and Central Asia. RADIAN was conceived with the partnership of Gilead Sciences. It focused on action, investment, care, and resources to improve the quality of life of people at risk of or living with HIV in the affected region.

More recently, in 2024, the Foundation introduced RADIAN 2.0, a new initiative to better implement RADIAN’s achievements to combat the HIV Epidemic in Eastern Europe and Central Asia.  The objectives of RADIAN 2.0 are:

  • To deliver community-based services to address the unmet needs of key populations and people living with HIV.
  • To address the key drivers of the HIV epidemic, to improve the quality of life of key populations and people living with HIV, and improve HIV-related health outcomes.
  • To strengthen health systems to improve care for key populations and people living with HIV.
  • To strengthen community systems to deliver community-led care and increase access to sustainable funding.

HIV and Poverty

Some structural drivers increase the HIV epidemic in Eastern Europe and Central Asia. The term structural drivers refers to “a range of factors, acting at macro and community levels, that fundamentally shape and influence patterns of HIV risk behaviour, and facilitate or impede an individual or group’s ability to access services and/or adhere to treatment” (STRIVE Research Consortium ), according to the Foundation. These structural drivers result in stigma and discrimination experienced by key populations and people living with HIV, which negatively affects their lives. This, in turn, contributes to the risk of contracting HIV, and then AIDS, and then dying. Some structural drivers of HIV include poor healthcare access, poor education, gendered violence, stigma and discrimination, and drug use.

How Does RADIAN 2.0 Help Combat HIV/AIDS?

RADIAN 2.0 works at the macro and community levels, creating structural interventions. At the macro level, the initiative may focus on changing discriminatory policies and legislation, improving economic and social conditions, modifying cultural and religious norms and changing the legal justice and law enforcement practices.

At the community level, the initiative may focus on reducing stigma and discrimination, creating educational and economic opportunities, changing gender norms and reducing inequality and improving access to health care services, according to the Foundation.

Why is RADIAN Important?

Eastern Europe and Central Asia are regions where new HIV infections and AIDS – related deaths are rising. Out of the 21 million people living with HIV, 41% are not aware that they have HIV, and 50% are not receiving treatment, which is below global targets. RADIAN, through its partnership with Gilead Sciences, was the Elton John Foundation’s answer to this growing problem.

Until the conception of RADIAN 2.0, RADIAN has significantly impacted the HIV response. With the help of local community services, RADIAN has reached over 310,000 people with essential HIV services and linked almost 35,700 people to HIV treatment. RADIAN 2.0 will build off the accomplishments of RADIAN in order to meet the changing needs of marginalized communities.

The Future

Even though HIV is declining globally, Eastern Europe and Central Asia are one of the regions where the HIV epidemic is worsening. In this region, new HIV diagnoses increased by 20%, and AIDS related deaths increased by 34% since 2010. “Over the next five years, RADIAN 2.0 will continue to address structural drivers of the epidemic, strengthen HIV health systems, and enhance the capacities of local organizations for a lasting impact,” says Daniel O’ Day, Chairman and Chief Executive Officer, Gilead Sciences. RADIAN has had a positive impact on HIV in Eastern Europe and Central Asia. It is hoped that RADIAN 2.0 will do the same.

Elton John created the Elton John AIDS Foundation in 1992 after losing loved ones to AIDS. He has worked to end the HIV epidemic once and for all. To put it in Elton John’s words, “All it takes is a bit more funding and a bit more understanding. All it takes is dialogue.”

– Abirame Shanthakumar

Abirame is based in Markham, Ontario, Canada and focuses on Celebs for The Borgen Project.

Photo: Wikimedia Commons

, ,

HIV/AIDS in Estonia

HIV/AIDS in EstoniaAuthorities reported the first HIV/AIDS case in Estonia in 1988. Since then, the number of people with HIV/AIDS in Estonia has decreased, but the country is still making progress.      

What Is HIV/AIDS?

HIV/AIDs is a virus that attacks a person’s immune system and weakens it, leading to an increased number and severity of infections. People can get HIV/AIDS by having sex with someone who has it and is not receiving proper medical treatment, or by sharing needles and other drug injection equipment with someone who has HIV/AIDS and is not receiving proper medical treatment.      

Without proper treatment, HIV leads to AIDS. Without treatment, someone with AIDS lives about three years. While there is no cure for HIV, people can get antiretroviral therapy, sometimes called ART. With ART, people with HIV can live long, happy lives.      

HIV/AIDS in Estonia

Most new HIV diagnoses in Estonia are in people over the age of 40. Authorities reported that more than half of the new cases of HIV/AIDS in Estonia in people who originally came from outside the country. As of 2023, most of the people who got HIV in Estonia contracted it from heterosexual sex (sex between a woman and a man).     

The capital city of Tallinn and North-Eastern Estonia report the majority of new cases. These areas also have the highest rate of people injecting drugs in the country.      

Treatment and Prevention of HIV/AIDS in Estonia

In 1987, Estonia started biological surveillance of HIV/AIDS. The government developed and adopted the first National Program for AIDS Prevention in 1992. Since then, the government has made improvements in the prevention and treatment of HIV/AIDS in Estonia.    

Since 2016, health care institutions provide free HIV testing, and pharmacies sell home HIV tests. Then, since 2017, family doctors in Estonia have had an unlimited budget for HIV testing. This has paid off as the number of people tested has increased since the 2000s.       

Cases of HIV/AIDS have decreased across the country. Particularly among young people. In 2001, there were 560 cases of HIV diagnosed in 15 to 19-year-olds. By 2016, doctors diagnosed only three cases among that age group.

A program of sex education that includes information about HIV/AIDS has been implemented in Estonian schools. The county has also launched multiple media campaigns focused on prompting the use of condoms and HIV testing.       

Poverty and HIV/AIDS can form a vicious cycle. Someone living in poverty is more likely to get HIV than someone who is not. The high cost of treatment can then further increase poverty. By having HIV testing be free, Estonia has addressed this problem.

Looking Ahead

The Estonian government and health organizations need to scale up HIV/AIDS testing and target it more effectively to vulnerable populations, such as sex workers and drug users. There is also a lack of proper preventative equipment, such as condoms and clean needles, within certain prisons in Estonia. However, with continued efforts to treat and prevent HIV/AIDS in Estonia, hopefully, it can become a thing of the past.

– Axtin Bullock 

Axtin is based in Georgetown, MA, USA and focuses on Global Health for The Borgen Project.

Photo: Unsplash

, ,

The Impact of Global Health Equity on Poverty in Kenya

The Impact of Global Health Equity on Poverty in KenyaDespite advances in economic development, millions of Kenyans still live in poverty. In 2022, about 40% of the population lived below the poverty line and at least 32% could not afford an adequate diet. This lack of basic resources prevents many people from living stable, productive lives, despite Kenya’s economic growth. The country has historically faced major health challenges. The prevalence of endemic diseases combined with a lack of access to adequate health care has exacerbated the impact of systemic poverty in Kenya.

Progress Through Global Health Initiatives

Kenya, with a rapidly growing population, is currently home to more than 57 million people. There are still significant social disparities between the rural and urban areas, as 85% of all poor people live in rural areas, while the majority of the urban poor live in slums. Achieving global health equity requires expanding access to clinics, life-saving medicines and trained health professionals.

Over the past two decades, various global health equity initiatives have improved the health landscape in Kenya. The government, supported by international organizations, has focused on preventing and treating infectious diseases like HIV/AIDS. Programs such as PEPFAR (President’s Emergency Plan for AIDS Relief), USAID and the World Health Organization (WHO) expanded access to clinics, medicines and trained professionals. These ongoing efforts have significantly improved health outcomes for citizens, leading to a reduction in poverty in Kenya.

Health Access and Economic Growth

Increased access to health care directly correlates with economic growth. Currently, the Kenyan economy is dominated by agriculture and informal micro-enterprises, which do not provide workers with any health coverage. Workers who cannot afford or access medical care often lose valuable workdays due to illness. Inadequate health care services exacerbate the effects of the epidemic diseases plaguing the nation. The inability to treat these diseases early on leads to increased medical costs. People suffer needlessly, children are too sick to go to school and the nation’s overall well-being and economy are affected, creating a vicious cycle of poverty in Kenya that cannot be stopped without health interventions.

HIV/AIDS: Evolution of Global Health Equity

Kenya’s efforts against HIV/AIDS offer an example of how targeted global health interventions can transform a nation’s future. In the late 1990s, HIV prevalence in Kenya was at an all-time high. By 1997, about 37% of men and 45% of women with a sexually transmitted infection also tested positive for HIV. Societal stigma and the high cost of ART limited access to treatment, while the country’s health care system struggled to manage the growing number of cases. This resulted in high mortality rates and large numbers of orphaned children.

To combat the crisis, international organizations began funding HIV relief efforts in Kenya. Groups such as PEPFAR, the Global Fund and USAID increased access to HIV testing, distributed ART and launched education campaigns. As of 2023, around 1.3 million Kenyans were receiving life-saving antiretroviral therapy.

Productivity Gains and Innovations in HIV Treatment

Modern ART has led to improvements in health and productivity for people living with HIV. A significant benefit has been an increase in the country’s productivity. In two studies focusing on agricultural workers in Kenya, researchers found that workers on ART doubled the number of days they could work each month. Participants also showed a 20% increase in labor force participation and a 35% increase in hours worked. These findings demonstrate the economic value of accessible health interventions.

Dr. Ann Kurth, an epidemiologist and leader in global health systems, spoke with The Borgen Project about Kenya’s progress. “Antiretrovirals came to sub-Saharan Africa and made transformative difference,” she said. “Health system strengthening by PEPFAR funding got you 26 million lives saved. Workforce training helped community health workers screen and test people for HIV in people’s homes with oral tests. We did a lot of self-testing in Kenya. These are innovations that were not the norm, but it helped people identify if they had HIV and get treated earlier.”

Equity and Inclusion in Health Care

Despite many advancements in global health equity in Kenya, significant challenges persist. Rural areas continue to struggle with shortages of medical professionals, transportation barriers and inadequate health care infrastructure. Shifting donor priorities can also affect long-term funding. Dr. Kurth emphasized the need for gender equity in care and research. Historically, clinical trials have underrepresented women and ignored key differences in how diseases and treatments affect them. “Women have not always been represented in clinical trials. A lot of assumptions about clinical practice are based on an assumption of it being a male body. There needs to be more gender representation in research and clinical services and not think of women as just about childbearing.”

Looking Ahead

Kenya’s commitment to improving health care access offers a model for other countries facing poverty. Strategic partnerships with international organizations have saved lives, built community resilience and contributed to reducing poverty in Kenya. Continued investment in health infrastructure, gender-inclusive research and rural outreach could be essential. As Dr. Kurth concluded, “We’ve been able to see major investments in the last couple of decades… That led to incredible child survival, maternal mortality improvements, increases in income and some advances in gender equality.”

– Rafe Photopoulos

Rafe is based in Gainesville, FL, USA and focuses on Global Health for The Borgen Project.

Photo: Flickr

, ,

Addressing HIV/AIDS in Morocco

HIV/AIDS in MoroccoThe HIV/AIDS epidemic in Morocco has had life-changing consequences for communities all over the world. International leaders have made significant progress over the past 30 years in improving awareness of the disease and accessibility to treatment, but countries must still take substantial action to fully eradicate it. Morocco has taken large strides towards this, launching various campaigns to do so. However, the extreme levels of poverty that the country is facing are forcing its residents into lifestyles that intensify their risk of contracting the disease, while the government’s lack of economic stability means prevention and treatment schemes are difficult to enact. Without U.S. support, the country lacks many resources which would be indispensable to its fight against HIV/AIDS in Morocco.

The Prevalence of HIV/AIDS in Morocco

As of 2024, the number of people living with HIV in Morocco stands at 23,000. About 5.9% of HIV/AIDS cases are men who engage in sexual relationships with other men (MSM), 7.1% are drug users and 2.3% are sex workers. The socio-political climate of Morocco still subjects these populations to extreme levels of discrimination, which often prevents them from seeking treatment. Additionally, 9% of Morocco’s population live currently in poverty. These difficult conditions, alongside the prevalence of sex tourism and human trafficking, mean there are an estimated 4.3 million sex workers living in Morocco, 2.3% of whom (knowingly) suffer from HIV.

The prevalence of drug users is also intertwined with national poverty, with economic stress forcing many to turn to substance abuse as a form of relief. The country’s lack of free health care also stands as a barrier to impoverished individuals accessing diagnoses and treatment, further increasing the risk of infection for those affected. Offering schemes to help alleviate the pressure of national poverty may prevent those it affects from turning to high-risk modes of employment and dangerous drug use, while making treatment accessible to those unable to afford healthcare bills. 

Breaking Down the Stigma

In comparison to other Middle Eastern and North African countries, the rate of HIV/AIDS among the population is relatively low. This is due to Morocco’s unmatched ability in implementing testing, diagnoses and treatment programs within its vulnerable communities. 

Thanks to the introduction of self-testing methods, the population now have access to a more discreet method of diagnosis. However, hospitals must still confirm tests offering positive results, limiting their anonymity and leading to a relatively low use rate.

Morocco’s ban on homosexuality, sex work and injection drugs, alongside general societal disapproval, means that many people who engage in these activities do not attempt to seek treatment for HIV/AIDS. 

In 2024 at the Taragalte Festival, Moroccan artist OUM announced that she would be ascending to the role of National Goodwill Ambassador in Morocco for UNAIDS. As a popular artist and social influencer, OUM’s work in spreading awareness and encouraging education about HIV prevention will be vital in breaking down the intense stigma surrounding the illness. UNAIDS foresaw that OUM’s efforts in erasing negative narratives via her public influence would improve access to HIV/AIDS preventative knowledge, diagnoses and treatment, particularly among high-risk communities in Morocco.

The US’s Impact

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), a campaign aimed at controlling the international HIV/AIDS epidemic, does not currently practice in Morocco. This means the country does not have access to U.S. funded resources that could have a significant impact on HIV/AIDS prevention and treatment and, due to the nation’s lower economic status, could not be financed by only their government. PEPFAR supports communities most vulnerable to the illness and with high-risk populations making up the majority of diagnoses in Morocco, the U.S. Department of State’s assistance could offer profound assistance in curbing the epidemic where it is most rife. 

HIV/AIDS in Morocco is preventable. Governmental strategies to combat the disease and its often poverty-rooted causes are already having a profound impact on decreasing its prevalence in the country. However, the epidemic requires further action to achieve total eradication. Reducing societal stigma is an important aspect of making treatment more accessible, but assisting those in poverty, through Moroccan and U.S. funded support, to obtain affordable healthcare schemes and engage in lower-risk lifestyles is by far the most crucial method of ending HIV/AIDS in Morocco for good.

– Amabel Smith

Amabel is based in London, UK and focuses on Global Health for The Borgen Project.

Photo: Unsplash